Navigation Links
AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
Date:5/7/2008

All amounts are in U.S. dollars

QUEBEC CITY, May 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results for the first quarter ended March 31, 2008.

First Quarter 2008 Highlights

- Cetrorelix: first patients treated in second efficacy trial of the

Phase 3 program in benign prostatic hyperplasia (BPH);

- AEZS-108: first patients treated in Phase 2 trial in ovarian and

endometrial cancers;

- Miltefosine (Impavido(R)): rights sold to Paladin Labs Inc. (TSX:PLB)

for approximately $8.9 million.

Subsequent to First Quarter End

- Cetrorelix: recruitment of 600 patients completed for first efficacy

trial of the Phase 3 program in BPH;

- Juergen Ernst, AEterna Zentaris Chairman, appointed Interim President

and CEO, replacing David J. Mazzo. Departure of Ellen McDonald, Senior

Vice President, Business Operations and Chief Business Officer;

- Board member Jose P. Dorais appointed to the Corporate Governance,

Nominating and Human Resources Committee, replacing Mr. Juergen Ernst,

the Company's Chairman of the Board and Interim President and CEO, who

had previously stepped down from the committee in connection with his

appointment as Interim President and CEO.

Juergen Ernst, Chairman, Interim President and CEO at AEterna Zentaris commented, "During the quarter, we continued to move forward with our Phase 3 program in BPH with our lead compound cetrorelix, as we completed patient recruitment for our first efficacy trial in North America and started
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Product and process impurities in biopharmaceuticals ... are often “lost in the noise,” making their ... Dr. Rowel Tobias, Senior Scientist, Protein Chemistry at ... Quality at Nanotherapeutics, Inc., to lear about a ... and quantitation while achieving the required specificity and ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, ... announce the relaunch of his highly informative blog, now named ... “ What are Stem Cells ?” Dr. Harman’s purpose ... in the basics of stem cell therapy so that pet ... of treatment when considering regenerative medicine. , A veterinarian by ...
(Date:7/10/2014)... 2014 On July 9 Prime ... presented Russia,s first national "Industry" ... Company is developing a unique project called MabNext ... a number of innovative drugs based on monoclonal antibodies ... took place at the International Exhibition "Innoprom 2014" in ...
(Date:7/10/2014)... to the International Atomic Energy Agency (IAEA) the ... acquiring sufficient quantities of plutonium or highly enriched ... device. The IAEA also notes that most cases ... which can be challenging to detect with most ... appearing this week in the Journal of ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Sensitive detection method may help impede illicit nuclear trafficking 2
... growing in prominence as viable vehicle and jet fuel ... processors and researchers of camelina have formed the first ... North America. The North American Camelina Trade Association ... development of new markets for camelina - a relatively ...
... Fatalities CitedLOS ANGELES, March 3 MMR ... which through its wholly-owned operating subsidiary, MyMedicalRecords, ... Records ("PHRs") ( www.mymedicalrecords.com ) and electronic ... ), announced that it is making its ...
... is smaller in diameter than a pencil. The DISMISS® instrument ... Invasive Spine Stabilization System and will be unveiled at the Congress ... 2009. , ... Winston-Salem, NC (PRWEB) March 3, 2009 ...
Cached Biology Technology:New Trade Association Formed for North America Camelina Industry 2New Trade Association Formed for North America Camelina Industry 3Drug Interaction Tool Offered Free in Response to Increasing At-Home Deaths From Medication Errors 2Drug Interaction Tool Offered Free in Response to Increasing At-Home Deaths From Medication Errors 3Drug Interaction Tool Offered Free in Response to Increasing At-Home Deaths From Medication Errors 4VGI Announces the Launch of DISMISS Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System 2
(Date:7/11/2014)... animals often develop relationships with other group members to ... wild chacma baboons the strategy for grooming activities shows ... just published in the scientific journal Biology Letters ... baboons is not practiced without ulterior motives. To be ... the individual, while grooming another individual can provide access ...
(Date:7/11/2014)... demonstrated that transplantation of mesenchymal stem cells can stimulate ... models of Alzheimer,s disease (AD) and improve tissue and ... studies are reported on the therapeutic effect of adipose-derived ... on the effect on oxidative injury and neurogenesis in ... her team, School of Life Sciences, Tsinghua University, China ...
(Date:7/11/2014)... the proteins that let nerve cells send out electrical ... a biological tactic that may offer a new way ... and environmentally responsible way. , Their findingthat naturally ... and harmless for a closely related onesuggests that insecticides ... beneficial species like bees. A summary of the research, ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3
... A new research paper from the labs of University ... helps resolve an ongoing debate about the assembly of ... cell function and disease. Goodson and her former postdoctoral ... M. Keck Center for Transgene Research) from the Department ...
... of Liverpool has been awarded 4million for a research and ... the spread of bacterial, viral and fungal infections. ... develop a new generation of surfaces and materials that are ... is significant global demand for products that prevent microbes from ...
... University] For years, researchers have been investigating how ... Dead Yet") affect metabolism, life span, and reproductive fitness ... in Indy have been studied experimentally only in the ... particularly important variation of the gene with much the ...
Cached Biology News:Paper offers insights into network that plays crucial role in cell function and disease 2Longevity mutation found in flies far and wide 2Longevity mutation found in flies far and wide 3
... Engine instrument is the cycler that ... thermal uniformity and swappable blocks ensure ... This rugged machine is more ... platform for new features and upgrades ...
... Xcell microbial system, 100 to 240 ... electroporation of bacterial and fungal cells. ... PC module for exponential decay delivery, ... (5 each of 0.1 and 0.2 ...
... Epithelial and endothelial cells-directed transfection ... RGD peptide-conjugated polyethylenimine which allows ... epithelial and endothelial cells. Integrins ... cell-cell and cell-matrix adhesion processes. ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~5 kDa thymosin beta4 protein....
Biology Products: